IL6R and Hepatic fibrosis: In addition, the Ingenuity Pathway Analysis predicted the impact on tryptophan, isoleucine, and valine pathways, hematopoiesis from pluripotent stem cells, hepatic fibrosis, retinoid X receptor activation, endocytosis, and the complement system by IL-6/IL-6R treatment (Figure 3E).